Table 3 Discordance in receptor status between different metastatic sites within the same patient.

From: Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution

Receptor

Discordant

Concordant

Discordant rate

ER

11

29

27.5%

PR

13

20

39.4%

HER2

5

30

14.3%

Back to article page